We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Oracle Corp | NYSE:ORCL | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.425 | -0.36% | 117.505 | 117.98 | 117.11 | 117.80 | 2,536,597 | 20:34:46 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ |
Preliminary Proxy Statement |
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
☐ |
Definitive Proxy Statement |
|
☒ |
Definitive Additional Materials |
|
☐ |
Soliciting Material Pursuant to Section 240.14a-12 |
Oracle Corporation
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ |
No fee required. |
|||
☐ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|||
(1) |
Title of each class of securities to which transaction applies:
|
|||
(2) |
Aggregate number of securities to which transaction applies:
|
|||
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|||
(4) |
Proposed maximum aggregate value of transaction:
|
|||
(5) |
Total fee paid:
|
|||
☐ |
Fee paid previously with preliminary materials. |
|||
☐ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|||
(1) |
Amount Previously Paid:
|
|||
(2) |
Form, Schedule or Registration Statement No.:
|
|||
(3) |
Filing Party:
|
|||
(4) |
Date Filed:
|
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting of
ORACLE CORPORATION
To Be Held On November 19, 2019 at 10:00 a.m., Pacific Time
in the Oracle Corporation Conference Center,
350 Oracle Parkway, Redwood City, California
COMPANY NUMBER
|
||||||
ACCOUNT NUMBER
|
||||||
CONTROL NUMBER
|
This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.
If you want to receive a paper or e-mail copy of the proxy materials, you must request one. There is no charge to you to receive a copy. To facilitate timely delivery please make the request as instructed below before 11/07/2019.
1. Election of Board of Directors: |
2. |
Advisory Vote to Approve the Compensation of the Named Executive Officers. |
|
|||||
NOMINEES: | 3. |
Ratification of the Selection of Ernst & Young LLP as Independent Registered Public Accounting Firm for Fiscal Year 2020. |
||||||
Jeffrey S. Berg Michael J. Boskin Safra A. Catz Bruce R. Chizen George H. Conrades Lawrence J. Ellison Rona A. Fairhead Hector Garcia-Molina Jeffrey O. Henley Mark V. Hurd Renée J. James Charles W. Moorman IV Leon E. Panetta William G. Parrett Naomi O. Seligman |
4. |
Stockholder Proposal Regarding Pay Equity Report. |
||||||
5. |
Stockholder Proposal Regarding Independent Board Chair. |
|||||||
The Board of Directors recommends a vote FOR all the nominees listed in Proposal 1, FOR Proposals 2 and 3, and AGAINST Proposals 4 and 5. |
||||||||
Please note that you cannot use this notice to vote by mail.
1 Year Oracle Chart |
1 Month Oracle Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions